TGFB1 and atherosclerosis: Although the significance of Smad3 protein of TGFβ pathway in ASCVD has been demonstrated in various genetic and knock down studies [15–24], development of non-toxic Smad3 inhibitors have been a challenge due to unknown mechanism and toxicity of inhibitors.